BBH
$165.51
VanEck Biotech ETF
Fund Family: VanEck ETF Trust
1 Month
+1.39%
YTD
-8.18%
1 Year
-8.18%
3 Year
+14.51%
Top 10 Holdings (70.8% of portfolio)
| Rank | Company | Ticker | Sector | Weight |
|---|---|---|---|---|
| 1 | Amgen Inc | AMGN | Manufacturing | 15.78% |
| 2 | Gilead Sciences Inc | GILD | Manufacturing | 13.35% |
| 3 | Vertex Pharmaceuticals Inc | VRTX | Manufacturing | 10.59% |
| 4 | Regeneron Pharmaceuticals Inc | REGN | Manufacturing | 5.11% |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | Manufacturing | 4.97% |
| 6 | ARGENX SE | ARGX | Manufacturing | 4.84% |
| 7 | Natera Inc | NTRA | Health Care and Social Assistance | 4.61% |
| 8 | IQVIA Holdings Inc | IQV | Health Care and Social Assistance | 4.51% |
| 9 | Insmed Inc | IM8N | Unknown | 3.65% |
| 10 | Biogen Inc | BIIB | Manufacturing | 3.44% |
Fund Information
| Net Assets | $330.62M | Expense Ratio | N/A |
| Total Holdings | 24 | Annual Fee* | N/A |
| Inception Date | N/A | Fund Family | VanEck ETF Trust |
*Annual fee per $10,000 invested